Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/2003
05/15/2003US20030092891 Expressed ligand - vascular intercellular signalling molecule
05/15/2003US20030092666 Compositions and methods for nucleic acid delivery to the lung
05/15/2003US20030092665 Methods and compositions for administering DNA to mucosal surfaces
05/15/2003US20030092664 Regulation of human epithin-like serine protease
05/15/2003US20030092660 Antiproliferative agents; anticancer agents; urogenital systems; insertion into cells
05/15/2003US20030092656 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting sustance against Wilms' tumor gene (WT1)
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092653 Method for inhibition of pathogenic microorganisms
05/15/2003US20030092652 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
05/15/2003US20030092647 Antisense modulation of cholesteryl ester transfer protein expression
05/15/2003US20030092645 Cloning, expression, viral and delivery vectors and hosts
05/15/2003US20030092618 Polypeptides, their production and use
05/15/2003US20030092611 Nucleic acids, proteins, and antibodies
05/15/2003US20030092182 Apparatus for use in the transfer of nucleotide sequences in to cells
05/15/2003US20030092180 Inhibition of gene expression by delivery of small interfering RNA to post-embryonic animal cells in vivo
05/15/2003US20030092162 Chimeric adenoviral vector for use as gene transfer tool
05/15/2003US20030092130 DNA encoding polypeptides having interferon-gamma inducing activity
05/15/2003US20030092120 Novel human K+ ion channel and therapeutic applications thereof
05/15/2003US20030092069 Hollow nanoparticle for use in the transfer of biopolymer into cells
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092050 Lipid A 4' kinase
05/15/2003US20030092046 Monomer for use in huaman therapeutics and diagnostics
05/15/2003US20030092042 Diagnosing cancer in mammals; obtain tissue sample, extract nucleotide sequences, detect galinin gene, determine copy number for gene, compare to control, amplified copy number indicates cancer
05/15/2003US20030092030 Wit 3.0, a novel gene to control soft tissue wound healing
05/15/2003US20030092011 Human cDNAs and proteins and uses thereof
05/15/2003US20030091996 Apoptin-associating protein
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091570 Analgesics; antiinflammatory agents; analyzing drug as to ability to modulation gene expression
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091551 Tyrosone kinase as insulin receptor; antidiabetic agents
05/15/2003US20030091548 Gene therapy for the prevention of autoimmune disease
05/15/2003US20030091546 Surgery removal of cell; transformation, transcription; reinsertion
05/15/2003US20030091544 Gene expression
05/15/2003US20030091543 Therapeutic cell preparation grafts and methods of use thereof
05/15/2003US20030091539 Use of DF3/MUC1 regulated expression in gene therapy
05/15/2003US20030091538 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
05/15/2003US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein
05/15/2003US20030091535 Mutant virus with defective genome; genetic engineering
05/15/2003CA2789407A1 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003CA2472097A1 Antisense modulation of purinoreceptor p2x3
05/15/2003CA2466880A1 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
05/15/2003CA2466391A1 Polyamide modulators of cox2 transcription
05/15/2003CA2466334A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2465950A1 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
05/15/2003CA2465886A1 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
05/15/2003CA2465476A1 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003CA2465361A1 Treatment of human cancer with adenoviral vector expressing tnf-.alpha.
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464626A1 Method for the in vitro synthesis of short double stranded rnas
05/15/2003CA2464007A1 Methods for treating ocular neovascular diseases
05/15/2003CA2463325A1 Novel proteins and nucleic acids encoding same
05/15/2003CA2462462A1 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003CA2460653A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2429147A1 Radiosensitivity enhancers, radiosensitivity-enhancing nucleic acids and proteins in cancer radiotherapy
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310561A1 Chimeric promoters for controlling expression in skeletal muscle cells
05/14/2003EP1310555A2 Oligonucleotide modulation of protein kinase C
05/14/2003EP1310554A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1309726A2 Rna sequence-specific mediators of rna interference
05/14/2003EP1309706A2 Modulation of stem cell differentiation
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309703A2 Kallikrein gene
05/14/2003EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309689A2 Genes involved in immune related responses observed with asthma
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309682A2 Tetraspan protein and uses thereof
05/14/2003EP1309679A2 Human genes and gene expression products
05/14/2003EP1309673A2 Pancreatic progenitor cells
05/14/2003EP1309625A2 Therapeutic compounds for ovarian cancer
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309603A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof
05/14/2003EP1309337A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage
05/14/2003EP0958382B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
05/14/2003EP0814838B1 Antigen presenting system and activation of t-cells
05/14/2003EP0800575B1 Method for gene transfer into cells activated out of a quiescent state
05/14/2003EP0666929B1 Method of inhibiting replication of hyperproliferative cells
05/14/2003EP0594669B1 Growth factor-responsive neural progenitor cells which can be proliferated in vitro.
05/14/2003CN1418255A Herpes virus strains for gene therapy
05/14/2003CN1418252A Use of paramyxovirus vector in gene transfer into blood vessel
05/14/2003CN1418248A Altered strain of modified vaccinia virus ankara (MVA)
05/14/2003CN1418224A TCF responsive element
05/14/2003CN1416903A Genetic medicine for treating cancer and other diseases characterized by run-off cell division and its prepn process
05/13/2003WO2002040048A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003US6562960 Oligonucleotide analogues
05/13/2003US6562957 Genomic sequence encoding endoglin and fragments thereof
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562619 Genration of preferential cell pools; prepare nutrient broth containing growth factor, inoculate with cells, propagate cells, recover cells
05/13/2003US6562596 Provides purified and isolated polypeptide products having primary structural conformation and biological properties of naturally occurring mammalian tissue inhibitor of metalloproteinase type three
05/13/2003US6562564 Decreasing cell proliferation by decreasing levels of PP5
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
1 ... 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 ... 870